JAMES V CARUSO
CIK 1202770 · Chief Executive Officer · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$45.3K
Companies
5
Total Filings
35
Lifetime Open-Market Net
-$2.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLRB | Chief Executive Officer | 20,318 | $2.23 | $45.3K | $74.9K | 7 | 2026-05-11 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | President and CEO | 86,401 | $0.12 | $10.3K | $45.1K | 10 | 2021-03-05 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | President and CEO | 6,000 | — | — | $8.3K | 4 | 2016-05-23 |
| Cellectar Biosciences, Inc. (CLRB.Z) Delisted | President and CEO | 47,548 | — | — | $99.5K | 1 | 2016-04-21 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Chief Commercial Officer | 103,659 | — | — | -$2.97M | 13 | 2010-03-03 |
Recent Filings · Page 2 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-05 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | +100,000 | $271.0K | EDGAR |
| 2019-01-18 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-30 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Buy (P) | +1,000 | $2.3K | EDGAR |
| 2018-10-15 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-14 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Sell (S) | −34,000 | -$40.7K | EDGAR |
| 2017-04-20 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | +200,000 | $0 | EDGAR |
| 2016-05-23 | Cellectar Biosciences, Inc. (CLRB.W) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-21 | Cellectar Biosciences, Inc. (CLRB.Z) Delisted | Buy (P) | +46,948 | $99.5K | EDGAR |
| 2015-11-25 | Cellectar Biosciences, Inc. (CLRB.W) Delisted | Buy (P) | +1,000 | $1.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.